糖尿病、肥胖与肾细胞癌病理升级:来自大型多机构联盟的结果
这项回顾性国际病例对照研究纳入2010年1月至2018年12月接受肾根治或肾部分切除术的非转移性肾细胞癌(cT1 N0)连续患者,分析术前危险因素与pT3a病理升级的关联。肾部分切除术患者升级率4.9%,根治术患者23.3%;糖尿病、较高BMI、术前肿瘤增大、年龄增加和男性与升级相关,肾门肿瘤也常被升级。
要点
- 肾部分切除术患者pT3a升级率4.9%,根治术患者为23.3%。
- 糖尿病与升级相关:肾部分切除术OR=1.65(95%CI 1.17,2.29)。
- 男性(OR=1.62)和BMI每增加1单位(OR=1.03)与升级相关。
核心结论
- 糖尿病和较高BMI与病理升级相关,术前肿瘤大小、年龄增加和男性也与升级相关,肾门肿瘤常被升级。
研究设计与样本
- 回顾性国际病例对照研究,纳入2010年1月至2018年12月间接受肾根治或肾部分切除术的非转移性肾细胞癌(cT1 N0)连续患者。
- 共纳入肾部分切除术4,092例和肾根治术2,056例患者。
主要发现
- 肾部分切除术患者病理升级发生率为4.9%,肾根治术患者为23.3%。
- 肾部分切除术患者中,糖尿病(OR=1.65;95%CI 1.17,2.29)、男性(OR=1.62;95%CI 1.14,2.33)和BMI每增加1单位(OR=1.03;95%CI 1.00,1.05)与升级有统计学关联。
- 肾门肿瘤更易升级:肾部分切除术OR=1.91(95%CI 1.12,3.16),肾根治术OR=2.16(95%CI 1.44,3.25)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: We sought to determine whether clinical risk factors and morphometric features on preoperative imaging can be utilized to identify those patients with cT1 tumors who are at higher risk of upstaging (pT3a). MATERIALS AND METHODS: We performed a retrospective international case-control study of consecutive patients treated surgically with radical or partial nephrectomy for nonmetastatic renal cell carcinoma (cT1 N0) conducted between January 2010 and December 2018. Multivariable logistic regression models were used to study associations of preoperative risk factors on pT3a pathological upstaging among all patients, as well as subsets with those with preoperative tumors ≤4 cm, renal nephrometry scores, tumors ≤4 cm with nephrometry scores, and clear cell histology. We also examined association with pT3a subsets (renal vein, sinus fat, perinephric fat). RESULTS: Among the 4,092 partial nephrectomy and 2,056 radical nephrectomy patients, pathological upstaging occurred in 4.9% and 23.3%, respectively. Among each group independent factors associated with pT3a upstaging were increasing preoperative tumor size, increasing age, and the presence of diabetes. Specifically, among partial nephrectomy subjects diabetes (OR=1.65; 95% CI 1.17, 2.29), male sex (OR=1.62; 95% CI 1.14, 2.33), and increasing BMI (OR=1.03; 95% CI 1.00, 1.05 per 1 unit BMI) were statistically associated with upstaging. Subset analyses identified hilar tumors as more likely to be upstaged (partial nephrectomy OR=1.91; 95% CI 1.12, 3.16; radical nephrectomy OR=2.16; 95% CI 1.44, 3.25). CONCLUSIONS: Diabetes and higher BMI were associated with pathological upstaging, as were preoperative tumor size, increased age, and male sex. Similarly, hilar tumors were frequently upstaged.
引用
- Pruthi DK, Miller G, Ankerst DP, et al. Diabetes, Obesity, and Pathological Upstaging in Renal Cell Carcinoma: Results From a Large Multi-institutional Consortium. J Urol. 2023. PMID: 37579345. doi:10.1097/JU.0000000000003650
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。